Home/Filings/4/0001209191-14-020348
4//SEC Filing

NxStage Medical, Inc. 4

Accession 0001209191-14-020348

CIK 0001333170operating

Filed

Mar 12, 8:00 PM ET

Accepted

Mar 13, 5:31 PM ET

Size

5.3 KB

Accession

0001209191-14-020348

Insider Transaction Report

Form 4
Period: 2014-03-10
Hershberger Kevin
Chief Accounting Officer
Transactions
  • Award

    Stock Option (right to buy)

    2014-03-10+15,23915,239 total
    Exercise: $14.66Exp: 2024-03-10Common Stock (15,239 underlying)
Footnotes (1)
  • [F1]The stock option becomes exercisable in 48 equal monthly installments beginning April 10, 2014.

Issuer

NxStage Medical, Inc.

CIK 0001333170

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001333170

Filing Metadata

Form type
4
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 5:31 PM ET
Size
5.3 KB